Exposure of endothelial cells to recombinant human erythropoietin induces nitric oxide synthase activity
- 1 May 2000
- journal article
- Published by Elsevier in Kidney International
- Vol. 57 (5), 1895-1904
- https://doi.org/10.1046/j.1523-1755.2000.00039.x
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Differential effects of an erythropoietin receptor gene disruption on primitive and definitive erythropoiesis.Genes & Development, 1996
- Erythropoietin modulation of intracellular calcium: a role for tyrosine phosphorylationCell Calcium, 1994
- Endothelial nitric oxide and cardiovascular diseaseJournal of Internal Medicine, 1994
- Antiplatelet therapy and development of hypertension induced by recombinant human erythropoietin in uremic patientsKidney International, 1994
- Erythropoietin increases cytosolic free calcium concentration and thrombin induced changes in cytosolic free calcium in platelets from spontaneously hypertensive ratsBiochemical and Biophysical Research Communications, 1991
- Direct vasopressor effect of recombinant human erythropoietin on renal resistance vesselsKidney International, 1991
- Endothelin action on vascular smooth muscle involves inositol trisphosphate and calcium mobilizationBiochemical and Biophysical Research Communications, 1989
- Endothelial Cell-Derived VasoconstrictorsJournal of Cardiovascular Pharmacology, 1989
- The Role of Endothelium in the Responses of Vascular Smooth Muscle to DrugsAnnual Review of Pharmacology and Toxicology, 1984
- The Hemodynamic Response to Chronic AnemiaCirculation, 1969